Interim Compensation Payments
Infected Blood Inquiry · First Interim Report · Issued 29 July 2022 · Addressed to: UK Government
Source — verbatim from the inquiry
●Inquiry recommendation
An interim payment, of no less than £100,000, should be paid to all those infected and all bereaved partners currently registered with any of the four UK infected blood support schemes, as well as those registering ahead of the inception of a future compensation scheme.
Infected Blood Inquiry, First Interim Report · 29 Jul 2022 Source PDF →
Published evidence summary
Publicly available evidence relating to this recommendation:
- The Government stated in August 2022 that it accepted this recommendation, and interim payments of £100,000 were made to infected individuals and bereaved partners registered with UK infected blood support schemes (Government Response to the Infected Blood Inquiry, Cabinet Office, December 2024).
- IBCA confirmed that as of 13 January 2026, 3,721 people had been asked to start claims, 3,074 had received offers totalling £2.47 billion, and 2,861 had been paid totalling £1.89 billion (IBCA Community Update, January 2026).
Response — verbatim from government
●UK Government — initial response
The Government accepted this recommendation on 17 August 2022. Interim payments of £100,000 were made to infected individuals and bereaved partners registered with UK infected blood support schemes beginning October 2022. By end of financial year 2022/23, approximately £440 million had been paid.
UK Government · 17 Aug 2022 Written response →
●UK Government — follow-up
The Government accepted this recommendation on 17 August 2022. Interim payments of £100,000 were made to infected individuals and bereaved partners registered with UK infected blood support schemes beginning October 2022. By end of financial year 2022/23, approximately £440 million had been paid.
UK Government · 14 May 2025 Written response →
●Department for Business and Trade — follow-up
The Government accepted this recommendation on 17 August 2022. Interim payments of £100,000 were made to infected individuals and bereaved partners registered with UK infected blood support schemes beginning October 2022. By end of financial year 2022/23, approximately £440 million had been paid.
Department for Business and Trade · 14 May 2025 Written response →
Evidence trail — what's actually happened since
- 17 Aug 2022 Interim payments completed. This was the first step toward full compensation, leading to establishment of IBCA and the full compensation scheme. Source →
- 15 Jan 2026 · IBCA Community Update As of 13 January 2026: 3,721 people asked to start claims, 3,546 begun process, 3,074 received offers totalling £2.47bn, 2,861 paid totalling £1.89bn. Third compensation regulations in force 31 December 2025. View source → Good Progress
- 31 Dec 2025 · UK Parliament Victims and Prisoners Act 2024 established IBCA. Three sets of scheme regulations in force (Aug 2024, Mar 2025, Dec 2025). First payments December 2024. £1.89bn paid to 2,861 people by January 2026. View source → Good Progress
- 28 Oct 2025 · IBCA Independent Review IBCA has contacted 2,215 people to begin compensation claims; 1,934 started process. £812m+ paid via Horizon Shortfall Scheme. £11.8bn committed in Autumn Budget. View source → Reasonable Progress
- 22 Jul 2025 · IBCA Community Update Infected Blood Compensation Authority established August 2024. First claims for deceased infected/affected opened December 2025. IBCA accepted all 11 recommendations directed to them. View source → Good Progress
Each entry above links to a primary source — gov.uk written statement, consultation response document, or inspection report. The Index does not characterise government intent; it tracks what has been published.
How this page is built
Source and Response are verbatim from primary documents. The Evidence trail records published activity since — written statements, consultation outcomes, inspection findings, parliamentary references. The Index does not paraphrase or characterise intent; it tracks what has been published. Where the evidence is the absence of action (a missed deadline, a slipped timetable), that absence is documented from primary sources rather than inferred.
This recommendation's data is verified periodically against primary sources. The Index is monitored for staleness weekly.